 | • レポートコード：QYR9NV17272 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の合成ポリペプチド薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。合成ポリペプチド薬の種類別には、免疫調節薬（アレルギー感染と免疫）、消化器系薬（胃腸型）、骨および結合組織型（甲状腺ホルモン薬）、婦人科または産科薬、腫瘍薬（hCG）、尿系薬（尿崩症）、その他に、用途別には、遺伝子送達、薬物送達、バイオイメージング、組織工学、抗菌薬、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・合成ポリペプチド薬の種類別市場規模：免疫調節薬（アレルギー感染と免疫）、消化器系薬（胃腸型）、骨および結合組織型（甲状腺ホルモン薬）、婦人科または産科薬、腫瘍薬（hCG）、尿系薬（尿崩症）、その他 ・合成ポリペプチド薬の用途別市場規模：遺伝子送達、薬物送達、バイオイメージング、組織工学、抗菌薬、その他 ・合成ポリペプチド薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Novartis、Thermo Fisher Scientific、Merck Millipore、Ferring Pharmaceuticals、AstraZeneca、HYBIO Pharmaceutical、Hainan Zhonghe Pharmaceutical、PolyPeptide、Abzena、CPC Scientific ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Polypeptide synthesis is the biological production of peptides, which are organic compounds in which multiple amino acids are linked via peptide bonds.In 2018, the global Synthesis Polypeptide Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Synthesis Polypeptide Drugs.
This study researches the market size of Synthesis Polypeptide Drugs, presents the global Synthesis Polypeptide Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Synthesis Polypeptide Drugs in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Synthesis Polypeptide Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
Thermo Fisher Scientific
Merck Millipore
Ferring Pharmaceuticals
AstraZeneca
HYBIO Pharmaceutical
Hainan Zhonghe Pharmaceutical
PolyPeptide
Abzena
CPC Scientific
Market Segment by Product Type
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug (hCG)
Urinary System Drug (Diabetes Insipidus)
Other
Market Segment by Application
Gene Delivery
Drug Delivery
Bio-Imaging
Tissue Engineering
Antimicrobials
Other
Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Synthesis Polypeptide Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Synthesis Polypeptide Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Synthesis Polypeptide Drugs are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Synthesis Polypeptide Drugs Market Size Growth Rate by Type
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug (hCG)
1.3.7 Urinary System Drug (Diabetes Insipidus)
1.3.8 Other
1.4 Market Segment by Application
1.4.1 Global Synthesis Polypeptide Drugs Market Share by Application (2019-2025)
1.4.2 Gene Delivery
1.4.3 Drug Delivery
1.4.4 Bio-Imaging
1.4.5 Tissue Engineering
1.4.6 Antimicrobials
1.4.7 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Synthesis Polypeptide Drugs Market Size
2.1.1 Global Synthesis Polypeptide Drugs Revenue 2014-2025
2.1.2 Global Synthesis Polypeptide Drugs Sales 2014-2025
2.2 Synthesis Polypeptide Drugs Growth Rate by Regions
2.2.1 Global Synthesis Polypeptide Drugs Sales by Regions 2014-2019
2.2.2 Global Synthesis Polypeptide Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Synthesis Polypeptide Drugs Sales by Manufacturers
3.1.1 Synthesis Polypeptide Drugs Sales by Manufacturers 2014-2019
3.1.2 Synthesis Polypeptide Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Synthesis Polypeptide Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Synthesis Polypeptide Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Synthesis Polypeptide Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Synthesis Polypeptide Drugs Price by Manufacturers
3.4 Key Manufacturers Synthesis Polypeptide Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Synthesis Polypeptide Drugs Market
3.6 Key Manufacturers Synthesis Polypeptide Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Immunity Regulating Medicine (Allergy Infection and Immune) Sales and Revenue (2014-2019)
4.1.2 Digestive System Drugs (Gastrointestinal Type) Sales and Revenue (2014-2019)
4.1.3 Bone and Connective Tissue Types (Thyroid hormones Drug) Sales and Revenue (2014-2019)
4.1.4 Gynecologic or Obstetric Drug Sales and Revenue (2014-2019)
4.1.5 Tumor Drug (hCG) Sales and Revenue (2014-2019)
4.1.6 Urinary System Drug (Diabetes Insipidus) Sales and Revenue (2014-2019)
4.1.7 Other Sales and Revenue (2014-2019)
4.2 Global Synthesis Polypeptide Drugs Sales Market Share by Type
4.3 Global Synthesis Polypeptide Drugs Revenue Market Share by Type
4.4 Synthesis Polypeptide Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Synthesis Polypeptide Drugs Sales by Application
6 North America
6.1 North America Synthesis Polypeptide Drugs Breakdown Data by Company
6.2 North America Synthesis Polypeptide Drugs Breakdown Data by Type
6.3 North America Synthesis Polypeptide Drugs Breakdown Data by Application
6.4 North America Synthesis Polypeptide Drugs Breakdown Data by Countries
6.4.1 North America Synthesis Polypeptide Drugs Sales by Countries
6.4.2 North America Synthesis Polypeptide Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Synthesis Polypeptide Drugs Breakdown Data by Company
7.2 Europe Synthesis Polypeptide Drugs Breakdown Data by Type
7.3 Europe Synthesis Polypeptide Drugs Breakdown Data by Application
7.4 Europe Synthesis Polypeptide Drugs Breakdown Data by Countries
7.4.1 Europe Synthesis Polypeptide Drugs Sales by Countries
7.4.2 Europe Synthesis Polypeptide Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Synthesis Polypeptide Drugs Breakdown Data by Company
8.2 Asia Pacific Synthesis Polypeptide Drugs Breakdown Data by Type
8.3 Asia Pacific Synthesis Polypeptide Drugs Breakdown Data by Application
8.4 Asia Pacific Synthesis Polypeptide Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Synthesis Polypeptide Drugs Sales by Countries
8.4.2 Asia Pacific Synthesis Polypeptide Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Synthesis Polypeptide Drugs Breakdown Data by Company
9.2 Central & South America Synthesis Polypeptide Drugs Breakdown Data by Type
9.3 Central & South America Synthesis Polypeptide Drugs Breakdown Data by Application
9.4 Central & South America Synthesis Polypeptide Drugs Breakdown Data by Countries
9.4.1 Central & South America Synthesis Polypeptide Drugs Sales by Countries
9.4.2 Central & South America Synthesis Polypeptide Drugs Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Synthesis Polypeptide Drugs Breakdown Data by Type
10.2 Middle East and Africa Synthesis Polypeptide Drugs Breakdown Data by Application
10.3 Middle East and Africa Synthesis Polypeptide Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Synthesis Polypeptide Drugs Sales by Countries
10.3.2 Middle East and Africa Synthesis Polypeptide Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.1.4 Synthesis Polypeptide Drugs Product Introduction
11.1.5 Novartis Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.2.4 Synthesis Polypeptide Drugs Product Introduction
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Merck Millipore
11.3.1 Merck Millipore Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.3.4 Synthesis Polypeptide Drugs Product Introduction
11.3.5 Merck Millipore Recent Development
11.4 Ferring Pharmaceuticals
11.4.1 Ferring Pharmaceuticals Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.4.4 Synthesis Polypeptide Drugs Product Introduction
11.4.5 Ferring Pharmaceuticals Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.5.4 Synthesis Polypeptide Drugs Product Introduction
11.5.5 AstraZeneca Recent Development
11.6 HYBIO Pharmaceutical
11.6.1 HYBIO Pharmaceutical Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.6.4 Synthesis Polypeptide Drugs Product Introduction
11.6.5 HYBIO Pharmaceutical Recent Development
11.7 Hainan Zhonghe Pharmaceutical
11.7.1 Hainan Zhonghe Pharmaceutical Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.7.4 Synthesis Polypeptide Drugs Product Introduction
11.7.5 Hainan Zhonghe Pharmaceutical Recent Development
11.8 PolyPeptide
11.8.1 PolyPeptide Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.8.4 Synthesis Polypeptide Drugs Product Introduction
11.8.5 PolyPeptide Recent Development
11.9 Abzena
11.9.1 Abzena Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.9.4 Synthesis Polypeptide Drugs Product Introduction
11.9.5 Abzena Recent Development
11.10 CPC Scientific
11.10.1 CPC Scientific Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Synthesis Polypeptide Drugs
11.10.4 Synthesis Polypeptide Drugs Product Introduction
11.10.5 CPC Scientific Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Synthesis Polypeptide Drugs Sales Channels
12.2.2 Synthesis Polypeptide Drugs Distributors
12.3 Synthesis Polypeptide Drugs Customers
13 Market Forecast
13.1 Global Synthesis Polypeptide Drugs Sales and Revenue Forecast 2019-2025
13.2 Global Synthesis Polypeptide Drugs Sales Forecast by Type
13.3 Global Synthesis Polypeptide Drugs Sales Forecast by Application
13.4 Synthesis Polypeptide Drugs Forecast by Regions
13.4.1 Global Synthesis Polypeptide Drugs Sales Forecast by Regions 2019-2025
13.4.2 Global Synthesis Polypeptide Drugs Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Synthesis Polypeptide Drugs Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Synthesis Polypeptide Drugs Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Synthesis Polypeptide Drugs Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Synthesis Polypeptide Drugs Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Synthesis Polypeptide Drugs Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Synthesis Polypeptide Drugs Product Picture
Table Synthesis Polypeptide Drugs Key Market Segments
Table Major Manufacturers Synthesis Polypeptide Drugs Covered in This Report
Table Global Synthesis Polypeptide Drugs Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Synthesis Polypeptide Drugs Sales Market Shar by Type 2014-2025
Figure Immunity Regulating Medicine (Allergy Infection and Immune) Figures
Table Major Manufacturers of Immunity Regulating Medicine (Allergy Infection and Immune)
Figure Digestive System Drugs (Gastrointestinal Type) Figures
Table Major Manufacturers of Digestive System Drugs (Gastrointestinal Type)
Figure Bone and Connective Tissue Types (Thyroid hormones Drug) Figures
Table Major Manufacturers of Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure Gynecologic or Obstetric Drug Figures
Table Major Manufacturers of Gynecologic or Obstetric Drug
Figure Tumor Drug (hCG) Figures
Table Major Manufacturers of Tumor Drug (hCG)
Figure Urinary System Drug (Diabetes Insipidus) Figures
Table Major Manufacturers of Urinary System Drug (Diabetes Insipidus)
Figure Other Figures
Table Major Manufacturers of Other
Table Global Synthesis Polypeptide Drugs Market Share by Application 2019-2025 (MT)
Figure Gene Delivery Use Case
Figure Drug Delivery Use Case
Figure Bio-Imaging Use Case
Figure Tissue Engineering Use Case
Figure Antimicrobials Use Case
Figure Other Use Case
Figure Synthesis Polypeptide Drugs Report Years Considered
Figure Global Synthesis Polypeptide Drugs Market Size 2014-2025 (Million US$)
Figure Global Synthesis Polypeptide Drugs Sales 2014-2019 (MT)
Table Global Synthesis Polypeptide Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Synthesis Polypeptide Drugs Sales by Regions 2014-2019 (MT)
Table Global Synthesis Polypeptide Drugs Sales Market Share by Regions 2014-2019
Figure Global Synthesis Polypeptide Drugs Sales Market Share by Regions 2014-2019
Figure Global Synthesis Polypeptide Drugs Sales Market Share by Regions in 2018
Table Global Synthesis Polypeptide Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Synthesis Polypeptide Drugs Revenue Market Share by Regions 2014-2019
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Regions 2014-2019
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Synthesis Polypeptide Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Synthesis Polypeptide Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Synthesis Polypeptide Drugs Sales Share by Manufacturers in 2018
Table Synthesis Polypeptide Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Synthesis Polypeptide Drugs Revenue Share by Manufacturers (2014-2019)
Figure Synthesis Polypeptide Drugs Value Share by Manufacturers in 2018
Table Global Synthesis Polypeptide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Synthesis Polypeptide Drugs Price (2014-2019) (USD/Kg)
Table Key Manufacturers Synthesis Polypeptide Drugs Plants/Factories Distribution
Table Key Manufacturers Synthesis Polypeptide Drugs Area Served
Table Date of Key Manufacturers Enter into Synthesis Polypeptide Drugs Market
Table Key Manufacturers Synthesis Polypeptide Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Immunity Regulating Medicine (Allergy Infection and Immune) Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Digestive System Drugs (Gastrointestinal Type) Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Bone and Connective Tissue Types (Thyroid hormones Drug) Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Gynecologic or Obstetric Drug Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Tumor Drug (hCG) Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Urinary System Drug (Diabetes Insipidus) Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Other Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Synthesis Polypeptide Drugs Sales by Type (2014-2019) (MT)
Table Global Synthesis Polypeptide Drugs Sales Share by Type (2014-2019)
Figure Global Synthesis Polypeptide Drugs Sales Market Share by Type (2014-2019)
Figure Global Synthesis Polypeptide Drugs Sales Market Share by Type in 2018
Table Global Synthesis Polypeptide Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Synthesis Polypeptide Drugs Revenue Share by Type (2014-2019)
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Type (2014-2019)
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Type in 2018
Table Synthesis Polypeptide Drugs Price by Type 2014-2019 (USD/Kg)
Table Global Synthesis Polypeptide Drugs Sales by Application (2014-2019) (MT)
Table Global Synthesis Polypeptide Drugs Sales Share by Application (2014-2019)
Figure Global Sales Synthesis Polypeptide Drugs Market Share by Application (2014-2019)
Figure Global Sales Synthesis Polypeptide Drugs Market Share by Application in 2018
Figure North America Synthesis Polypeptide Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Synthesis Polypeptide Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Synthesis Polypeptide Drugs Sales by Company (2014-2019) (MT)
Table North America Synthesis Polypeptide Drugs Sales Market Share by Company (2014-2019)
Figure North America Synthesis Polypeptide Drugs Sales Market Share by Company in 2018
Table North America Synthesis Polypeptide Drugs Sales by Type (2014-2019) (MT)
Table North America Synthesis Polypeptide Drugs Sales Market Share by Type (2014-2019)
Figure North America Synthesis Polypeptide Drugs Market Share by Type in 2018
Table North America Synthesis Polypeptide Drugs Sales by Application (2014-2019) (MT)
Table North America Synthesis Polypeptide Drugs Sales Market Share by Application (2014-2019)
Figure North America Synthesis Polypeptide Drugs Market Share by Application in 2018
Table North America Synthesis Polypeptide Drugs Sales by Countries (2014-2019) (MT)
Table North America Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure North America Synthesis Polypeptide Drugs Sales Market Share by Countries in 2018
Table North America Synthesis Polypeptide Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure United States Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Europe Synthesis Polypeptide Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Synthesis Polypeptide Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Synthesis Polypeptide Drugs Sales by Company (2014-2019) (MT)
Table Europe Synthesis Polypeptide Drugs Sales Market Share by Company (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Sales Market Share by Company in 2018
Table Europe Synthesis Polypeptide Drugs Sales by Type (2014-2019) (MT)
Table Europe Synthesis Polypeptide Drugs Sales Market Share by Type (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Sales Market Share by Type in 2018
Table Europe Synthesis Polypeptide Drugs Sales by Application (2014-2019) (MT)
Table Europe Synthesis Polypeptide Drugs Sales Market Share by Application (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Sales Market Share by Application in 2018
Table Europe Synthesis Polypeptide Drugs Sales by Countries (2014-2019) (MT)
Table Europe Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Sales Market Share by Countries in 2018
Table Europe Synthesis Polypeptide Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure Germany Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Asia Pacific Synthesis Polypeptide Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Synthesis Polypeptide Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Synthesis Polypeptide Drugs Sales by Regions (2014-2019) (MT)
Table Asia Pacific Synthesis Polypeptide Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Synthesis Polypeptide Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Synthesis Polypeptide Drugs Sales by Type (2014-2019) (MT)
Table Asia Pacific Synthesis Polypeptide Drugs Sales Market Share by Type (2014-2019)
Figure Asia Pacific Synthesis Polypeptide Drugs Market Share by Type in 2018
Table Asia Pacific Synthesis Polypeptide Drugs Sales by Application (2014-2019) (MT)
Table Asia Pacific Synthesis Polypeptide Drugs Sales Market Share by Application (2014-2019)
Figure Asia Pacific Synthesis Polypeptide Drugs Market Share by Application in 2018
Table Asia Pacific Synthesis Polypeptide Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Synthesis Polypeptide Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Synthesis Polypeptide Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Synthesis Polypeptide Drugs Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Synthesis Polypeptide Drugs Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Synthesis Polypeptide Drugs Revenue Market Share by Regions in 2018
Figure China Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Synthesis Polypeptide Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Synthesis Polypeptide Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Synthesis Polypeptide Drugs Sales by Company (2014-2019) (MT)
Table Central & South America Synthesis Polypeptide Drugs Sales Market Share by Company (2014-2019)
Figure Central & South America Synthesis Polypeptide Drugs Sales Market Share by Company in 2018
Table Central & South America Synthesis Polypeptide Drugs Sales by Type (2014-2019) (MT)
Table Central & South America Synthesis Polypeptide Drugs Sales Market Share by Type (2014-2019)
Figure Central & South America Synthesis Polypeptide Drugs Market Share by Type in 2018
Table Central & South America Synthesis Polypeptide Drugs Sales by Application (2014-2019) (MT)
Table Central & South America Synthesis Polypeptide Drugs Sales Market Share by Application (2014-2019)
Figure Central & South America Synthesis Polypeptide Drugs Market Share by Application in 2018
Table Central & South America Synthesis Polypeptide Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure Central & South America Synthesis Polypeptide Drugs Sales Market Share by Countries in 2018
Table Central & South America Synthesis Polypeptide Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure Central & South America Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure Brazil Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Middle East and Africa Synthesis Polypeptide Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Synthesis Polypeptide Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales by Type (2014-2019) (MT)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Type in 2018
Table Middle East and Africa Synthesis Polypeptide Drugs Sales by Application (2014-2019) (MT)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Application in 2018
Table Middle East and Africa Synthesis Polypeptide Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Synthesis Polypeptide Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure GCC Countries Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Egypt Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (MT)
Figure South Africa Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Synthesis Polypeptide Drugs Revenue Growth Rate (2014-2019) (MT)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novartis Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table Novartis Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table Novartis Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Description and Business Overview
Table Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table Thermo Fisher Scientific Recent Development
Table Merck Millipore Company Details
Table Merck Millipore Description and Business Overview
Table Merck Millipore Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck Millipore Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table Merck Millipore Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table Merck Millipore Recent Development
Table Ferring Pharmaceuticals Company Details
Table Ferring Pharmaceuticals Description and Business Overview
Table Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table Ferring Pharmaceuticals Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table AstraZeneca Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table AstraZeneca Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table HYBIO Pharmaceutical Company Details
Table HYBIO Pharmaceutical Description and Business Overview
Table HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table HYBIO Pharmaceutical Recent Development
Table Hainan Zhonghe Pharmaceutical Company Details
Table Hainan Zhonghe Pharmaceutical Description and Business Overview
Table Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table Hainan Zhonghe Pharmaceutical Recent Development
Table PolyPeptide Company Details
Table PolyPeptide Description and Business Overview
Table PolyPeptide Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table PolyPeptide Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table PolyPeptide Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table PolyPeptide Recent Development
Table Abzena Company Details
Table Abzena Description and Business Overview
Table Abzena Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Abzena Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table Abzena Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table Abzena Recent Development
Table CPC Scientific Company Details
Table CPC Scientific Description and Business Overview
Table CPC Scientific Synthesis Polypeptide Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table CPC Scientific Synthesis Polypeptide Drugs Sales Growth Rate (2014-2019)
Table CPC Scientific Synthesis Polypeptide Drugs Sales Market Share in Global Market
Table CPC Scientific Recent Development
Figure Synthesis Polypeptide Drugs Value Chain
Table Synthesis Polypeptide Drugs Distributors List
Table Synthesis Polypeptide Drugs Customers List
Table Global Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT) & (Million US$)
Figure Global Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Global Synthesis Polypeptide Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Synthesis Polypeptide Drugs Sales Forecast by Type 2019-2025 (MT)
Figure Global Synthesis Polypeptide Drugs Sales Forecast by Type 2019-2025 (MT)
Figure Global Synthesis Polypeptide Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Synthesis Polypeptide Drugs Sales Forecast by Application 2019-2025 (MT)
Figure Global Synthesis Polypeptide Drugs Sales Forecast by Application 2019-2025 (MT)
Figure Global Synthesis Polypeptide Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Synthesis Polypeptide Drugs Sales Forecast by Regions 2019-2025 (MT)
Figure Global Synthesis Polypeptide Drugs Sales Forecast by Regions 2019-2025 (MT)
Figure Global Synthesis Polypeptide Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Synthesis Polypeptide Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Synthesis Polypeptide Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Synthesis Polypeptide Drugs Revenue Market Share Forecast by Regions 2019-2025
Table North America Synthesis Polypeptide Drugs Sales Forecast by Countries 2019-2025 (MT)
Table North America Synthesis Polypeptide Drugs Sales Market Share Forecast by Countries 2019-2025
Table North America Synthesis Polypeptide Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Synthesis Polypeptide Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure United States Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Canada Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Mexico Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Table Europe Synthesis Polypeptide Drugs Sales Forecast by Countries 2019-2025 (MT)
Table Europe Synthesis Polypeptide Drugs Sales Market Share Forecast by Countries 2019-2025
Table Europe Synthesis Polypeptide Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Synthesis Polypeptide Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure France Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure UK Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Italy Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Russia Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Table Asia Pacific Synthesis Polypeptide Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Asia Pacific Synthesis Polypeptide Drugs Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Synthesis Polypeptide Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Synthesis Polypeptide Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure China Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Japan Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure South Korea Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure India Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Australia Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Indonesia Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Thailand Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Malaysia Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Philippines Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Vietnam Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Table Central & South America Synthesis Polypeptide Drugs Sales Forecast by Countries 2019-2025 (MT)
Table Central & South America Synthesis Polypeptide Drugs Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Synthesis Polypeptide Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Synthesis Polypeptide Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Synthesis Polypeptide Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Synthesis Polypeptide Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure GCC Countries Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure Egypt Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Figure South Africa Synthesis Polypeptide Drugs Sales Forecast 2019-2025 (MT)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の合成ポリペプチド薬産業調査2019-2025 Polypeptide synthesis is the biological production of peptides, which are organic compounds in which multiple amino acids are linked via peptide bonds.In 2018, the global Synthesis Polypeptide Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% fro…- ポリペプチド薬のグローバル市場調査 2019年 The global Polypeptide Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polypeptide Drug volume and value at global level, regional level and company level. From a global perspective, this repor…
- ポリペプチド薬のグローバル市場調査 2019年 The global Polypeptide Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polypeptide Drug volume and value at global level, regional level and company level. From a global perspective, this repor…
- 世界及び中国の消化器系薬市場2018 The 'Global and Chinese Digestive System Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Digestive System Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Digestiv…
- 消化器系薬のグローバル市場調査 2019年 The global Digestive System Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Digestive System Drug volume and value at global level, regional level and company level. From a global perspective, …